4.4 Article

Induction of TNF-α in human macrophages by avian and human influenza viruses

Journal

ARCHIVES OF VIROLOGY
Volume 155, Issue 8, Pages 1273-1279

Publisher

SPRINGER WIEN
DOI: 10.1007/s00705-010-0716-y

Keywords

-

Categories

Funding

  1. Thailand Research Fund [BRG5180008]
  2. JSPS (Japan Society for the Promotion of Science)
  3. Mahidol Medical Scholar Program
  4. National Institute of Allergy and Infectious Diseases Public Health Service
  5. NIAID, Center for Research on Influenza Pathogenesis (CRIP) [HHSN266200700010C]
  6. Ministry of Education, Culture, Sports, Science, and Technology
  7. Ministry of Health
  8. ERATO (Japan Science and Technology Agency)
  9. US CDC

Ask authors/readers for more resources

The highly pathogenic avian influenza virus H5N1 is known to induce high level of tumor necrosis factor alpha (TNF-alpha) from primary macrophages. However, it is still unclear whether current H5N1 strains also induce high TNF-alpha production, as most of the data were derived from extinct clade 0 H5N1 strain. Here, we show that current clade 1 and 2 H5N1 strains induce variable levels of TNF-alpha that are not necessarily higher than those induced by seasonal influenza viruses. The result suggests that hyper-induction of TNF-alpha in human macrophages is not always associated with a highly pathogenic phenotype. We further tested the contribution of the NS gene segment from H5N1 isolates to TNF-alpha induction by using reverse genetics. While NS conferred some variation in TNF-alpha induction when incorporated into an H1N1 virus genetic background, it did not affect TNF-alpha induction in an H5N1 virus genetic background, suggesting that other viral genes are involved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Emergency Medicine

Reliability of capillary refill time for evaluation of tissue perfusion in simulated vascular occluded limbs

Yuwarat Monteerarat, Roongsak Limthongthang, Panai Laohaprasitiporn, Torpon Vathana

Summary: This study investigated the reliability and validity of CRT, and found that CRT is reliable when used at appropriate areas. The most dependable site is the finger pulp, with a proposed cutoff of 3 seconds.

EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY (2022)

Article Virology

Receptor binding domain proteins of SARS-CoV-2 variants produced in Nicotiana benthamiana elicit neutralizing antibodies against variants of concern

Narach Khorattanakulchai, Suwimon Manopwisedjaroen, Kaewta Rattanapisit, Chalisa Panapitakkul, Taratorn Kemthong, Nutchanat Suttisan, Kanjana Srisutthisamphan, Suchinda Malaivijitnond, Arunee Thitithanyanont, Anan Jongkaewwattana, Balamurugan Shanmugaraj, Waranyoo Phoolcharoen

Summary: The spread of SARS-CoV-2 variants poses a severe public health problem globally, necessitating the development of effective vaccines and optimized booster vaccination strategies. This study demonstrates that plant-produced RBD-Fc vaccines can enhance the immune response against various SARS-CoV-2 variants. The Delta and Epsilon RBD-Fc vaccines show cross-reactive immunogenicity and have the potential to induce broadly neutralizing antibodies.

JOURNAL OF MEDICAL VIROLOGY (2022)

Article Immunology

Dynamics of Neutralizing Antibodies and Binding Antibodies to Domains of SARS-CoV-2 Spike Protein in COVID-19 Survivors

Supinya Phakaratsakul, Suwimon Manopwisedjaroen, Chompunuch Boonarkart, Pawinee Kupatawintu, Dootchai Chaiwanichsiri, Thaneeya Roytrakul, Prasert Auewarakul, Arunee Thitithanyanont

Summary: The study observed the longitudinal changes in antibody levels of COVID-19 recovered patients, showing differences in dynamics between neutralizing antibodies and binding antibodies. Some patients had consistently high levels of neutralizing antibodies, while their binding antibodies rapidly decreased. Additionally, the presence of binding antibodies to S2 suggested an immune response to other coronaviruses.

VIRAL IMMUNOLOGY (2022)

Article Plant Sciences

A recombinant subunit vaccine candidate produced in plants elicits neutralizing antibodies against SARS-CoV-2 variants in macaques

Narach Khorattanakulchai, Kanjana Srisutthisamphan, Balamurugan Shanmugaraj, Suwimon Manopwisedjaroen, Kaewta Rattanapisit, Chalisa Panapitakkul, Taratorn Kemthong, Nutchanat Suttisan, Suchinda Malaivijitnond, Arunee Thitithanyanont, Anan Jongkaewwattana, Waranyoo Phoolcharoen

Summary: The three-dose regimen of Baiya SARS-CoV-2 Vax 1 vaccine elicits a neutralizing immune response against SARS-CoV-2 variants.

FRONTIERS IN PLANT SCIENCE (2022)

Article Biotechnology & Applied Microbiology

Boosting the detection performance of severe acute respiratory syndrome coronavirus 2 test through a sensitive optical biosensor with new superior antibody

Chih-Yen Lin, Wen-Hung Wang, Meng-Chi Li, Yu-Ting Lin, Zih-Syuan Yang, Aspiro Nayim Urbina, Wanchai Assavalapsakul, Arunee Thitithanyanont, Kai-Ren Chen, Chien-Cheng Kuo, Yu-Xen Lin, Hui-Hua Hsiao, Kun-Der Lin, Shang-Yi Lin, Yen-Hsu Chen, Ming-Lung Yu, Li-Chen Su, Sheng-Fan Wang

Summary: In this study, a quick and precise phase-sensitive surface plasmon resonance (PS-SPR) biosensor integrated with a newly generated anti-S monoclonal antibody was developed for highly sensitive detection of SARS-CoV-2 and its variants.

BIOENGINEERING & TRANSLATIONAL MEDICINE (2023)

Article Dermatology

A real-world prospective cohort study of immunogenicity and reactogenicity of ChAdOx1-S[recombinant] among patients with immune-mediated dermatological diseases

Kumutnart Chanprapaph, Chutima Seree-aphinan, Ploysyne Rattanakaemakorn, Cherrin Pomsoong, Yanisa Ratanapokasatit, Chavachol Setthaudom, Arunee Thitithanyanont, Aphinyaphiwat Suriyo, Thanitta Suangtamai, P. Suchonwanit, COVIDVAC DERM study Grp

Summary: A study investigated the impact of immune-mediated dermatological diseases (IMDDs) on SARS-CoV-2-specific immunity and side effects after ChAdOx1-S [recombinant] vaccination, and found that patients with IMDDs had lower immunogenicity and may require treatment escalation.

BRITISH JOURNAL OF DERMATOLOGY (2023)

Article Infectious Diseases

Immunogenicity of a fractional or full third dose of AZD1222 vaccine or BNT162b2 messenger RNA vaccine after two doses of CoronaVac vaccines against the Delta and Omicron variants

Suvimol Niyomnaitham, Anan Jongkaewwattana, Atibordee Meesing, Nawamin Pinpathomrat, Sira Nanthapisal, Nattiya Hirankarn, Sarawut Siwamogsatham, Suppachok Kirdlarp, Romanee Chaiwarith, Saranath Lawpoolsri, Supranee Phanthanawiboon, Arunee Thitithanyanont, Pokrath Hansasuta, Sansanee Chaiyaroj, Punnee Pitisuttithum

Summary: This study aimed to compare the immunogenicity and safety of fractional (half) third doses of heterologous COVID-19 vaccines (AZD1222 or BNT162b2) to full doses after the two-dose CoronaVac and when boosting after three different extended intervals. The results showed no difference in immunogenicity between half doses and full doses, but the full doses and longer intervals substantially improved immunogenicity.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2023)

Article Virology

Analysis of Influenza A virus infection in human induced pluripotent stem cells (hiPSCs) and their derivatives

Kanyarat Ruangrung, Warunya Chakritbudsabong, Songkran Thongon, Sasitorn Rungarunlert, Methichit Wattanapanitch, Chompunuch Boonarkart, Ornpreya Suptawiwat, Naraporn Sirinonthanawech, Duncan Richard Smith, Prasert Auewarakul

Summary: The study found that human induced pluripotent stem cells (hiPSCs) and their derived ectodermal, mesodermal, and endodermal cells are susceptible to infection by Influenza A virus (IAV). These cells express the receptor for IAV infection, alpha 2,6-linked sialic acid, on their surface. While hiPSCs could produce infectious viral progenies for up to 7 days and spread to other cells, the germ-layer cells showed a decline in viral titers, indicating a lack of viral spreading. Among the three germ layers, endodermal cells were found to be less susceptible to IAV infection. These findings suggest a potential risk of detrimental effects of IAV infection on early human embryonic development.

VIRUS RESEARCH (2023)

Article Infectious Diseases

A Pilot Study of 0.4% Povidone-Iodine Nasal Spray to Eradicate SARS-CoV-2 in the Nasopharynx

Rujipas Sirijatuphat, Amorn Leelarasamee, Thanapat Puangpet, Arunee Thitithanyanont

Summary: This study evaluated the virucidal efficacy of 0.4% PVP-I nasal spray against SARS-CoV-2 in the patients' nasopharynx. The results showed that viral titers were reduced in some patients at 3 minutes post-spray, but there was minimal change in viral titers at 4 hours post-spray. The 0.4% PVP-I nasal spray demonstrated poor virucidal activity and is unlikely to reduce transmission of SARS-CoV-2 in prophylaxis use.

INFECTION AND DRUG RESISTANCE (2022)

Article Integrative & Complementary Medicine

In silico and in vitro studies of potential inhibitors against Dengue viral protein NS5 Methyl Transferase from Ginseng and Notoginseng

Viwan Jarerattanachat, Chompunuch Boonarkart, Supa Hannongbua, Prasert Auewarakul, Ruchuta Ardkhean

Summary: This study identified Isoquercitrin, a compound found in Ginseng and Notoginseng, as a potential inhibitor of Dengue NS5 protein. Isoquercitrin showed significant antiviral activity against Dengue virus by reducing viral RNA and protein synthesis with low cell toxicity.

JOURNAL OF TRADITIONAL AND COMPLEMENTARY MEDICINE (2023)

Article Chemistry, Analytical

Facile and Unplugged Surface Plasmon Resonance Biosensor with NIR-Emitting Perovskite Nanocomposites for Fast Detection of SARS-CoV-2

Lung-Chien Chen, Meng-Chi Li, Kai-Ren Chen, Yu-Jui Cheng, Xun-Ying Wu, Sih-An Chen, Meng-Jey Youh, Chien-Cheng Kuo, Yu-Xen Lin, Chih-Yen Lin, Chu-Feng Wang, Chung-Feng Huang, Shang-Yi Lin, Wen-Hung Wang, Yen-Hsu Chen, Ming-Lung Yu, Arunee Thitithanyanont, Sheng-Fan Wang, Li-Chen Su

Summary: Researchers developed a wavelength-based SPR sensor using 3D printing technology and synthesized stable NIR-emitting perovskite nanocomposites. This portable sensor can detect the coronavirus in a quick and simple manner, making it suitable for on-site detection.

ANALYTICAL CHEMISTRY (2023)

Article Evolutionary Biology

Systematic Exploration of SARS-CoV-2 Adaptation to Vero E6, Vero E6/TMPRSS2, and Calu-3 Cells

Pakorn Aiewsakun, Worakorn Phumiphanjarphak, Natali Ludowyke, Priyo Budi Purwono, Suwimon Manopwisedjaroen, Chanya Srisaowakarn, Supanuch Ekronarongchai, Ampa Suksatu, Jirundon Yuvaniyama, Arunee Thitithanyanont

Summary: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread globally, and scientists have found that the virus undergoes cell culture adaptation during laboratory growth. This study systematically explored the cell culture adaptation of two SARS-CoV-2 variants propagated in different cell lines, revealing numerous potential adaptation changes across the viral genome. The results highlight the high adaptability of SARS-CoV-2 and emphasize the importance of deep-sequencing cultured viral samples for intricate and sensitive biological experiments.

GENOME BIOLOGY AND EVOLUTION (2023)

Article Immunology

Preclinical evaluation of immunogenicity, efficacy and safety of a recombinant plant-based SARS-CoV-2 RBD vaccine formulated with 3M-052-Alum adjuvant

Waranyoo Phoolcharoen, Balamurugan Shanmugaraj, Narach Khorattanakulchai, Piyanate Sunyakumthorn, Sathit Pichyangkul, Pornnarin Taepavarapruk, Wanlapa Praserthsee, Suchinda Malaivijitnond, Suwimon Manopwisedjaroen, Arunee Thitithanyanont, Kanjana Srisutthisamphan, Anan Jongkaewwattana, Mark Tomai, Christopher B. Fox, Suthira Taychakhoonavudh

Summary: Cost-effective and accessible vaccines are crucial for mass immunization against COVID-19, especially in LMIC. A preclinical study evaluated the immunogenicity, efficacy, and safety of a plant-based SARSCoV-2 RBD vaccine with 3M-052 (TLR7/8 agonist)-Alum adjuvant. The vaccine induced significant antibody responses and immune protection against SARSCoV-2.

VACCINE (2023)

Article Virology

Human Schlafen 11 inhibits influenza A virus production

Kunlakanya Jitobaom, Thanyaporn Sirihongthong, Chompunuch Boonarkart, Supinya Phakaratsakul, Ornpreya Suptawiwat, Prasert Auewarakul

Summary: Schlafen (SLFN) proteins are interferon-stimulated early response genes that have antiviral properties. Previous research has demonstrated the antiviral mechanism of SLFN11 in inhibiting HIV-1 virus production in a codon usage-specific manner. This study investigates the effect of SLFN11 on influenza A virus (IAV) replication and finds that SLFN11 inhibits IAV in a codon-specific manner, suggesting its potential role in innate defense against IAV.

VIRUS RESEARCH (2023)

Article Biochemistry & Molecular Biology

DC-SIGN and Galectin-3 individually and collaboratively regulate H5N1 and H7N9 avian influenza A virus infection via interaction with viral envelope hemagglutinin protein

Zih-Syuan Yang, Wen-Hung Wang, Yu-Ting Lin, Chih-Yen Lin, Aspiro Nayim Urbina, Arunee Thitithanyanont, Po-Liang Lu, Yen-Hsu Chen, Sheng-Fan Wang

Summary: This study investigates the individual and collaborative roles of DC-SIGN and Gal3 in H5N1 and H7N9 avian influenza virus (AIV) infection. It is found that DC-SIGN expression significantly promotes viral infection, while Gal3 knockdown reduces viral infection. The co-expression of DC-SIGN and Gal3 enhances infectivity of H5N1 and H7N9 viruses, with stronger regulatory capabilities for H5N1. The study reveals the significance of DC-SIGN and Gal3 in regulating AIV infection and suggests the potential of targeting their interaction with HA protein as antiviral strategies.

GLYCOBIOLOGY (2023)

No Data Available